GT Biopharma
GTBP
GTBP
33 hedge funds and large institutions have $895K invested in GT Biopharma in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% less ownership
Funds ownership: 0.28% → 0.28% (-0.01%)
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14.1K | |
| 2 | +$11.7K | |
| 3 | +$8.36K | |
| 4 |
HF
HRT Financial
New York
|
+$8.23K |
| 5 |
MG
Marex Group
London,
|
+$7.31K |
Top Sellers
| 1 | -$36K | |
| 2 | -$12.1K | |
| 3 | -$5.38K | |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$4.92K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.36K |